1988
DOI: 10.5144/0256-4947.1988.470
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis B Virus Markers among the Blood Donors in Medina Munawara

Abstract: Three hundred sixty-nine male blood donors from Medina Munawara were studied for hepatitis B virus (HBV) markers. Serologic evidence of exposure to HBV was noted in 48%. A majority of these individuals showed the presence of antibodies, and only 7.6% were documented as HBsAg carriers. The infection was usually caused by HBV subtype ay. A strong positive correlation existed between infection rate, age, and poor socioeconomic conditions. We presume that improvement in the socioeconomic conditions and timely vacc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1995
1995
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 15 publications
(20 reference statements)
0
1
0
Order By: Relevance
“…6,8 However several surveys of voluntary blood donors in the Kingdom of Saudi Arabia have shown marked regional variations in the prevalence of HBV. [9][10][11][12] In the region of Tabuk, which occupies the northwestern part of Saudi Arabia, information on the epidemiology and prevalence of HBV infection among the different population groups is inadequate. Most of the previous studies in the region have been limited to children less than 12 years of age as part of national studies aiming at evaluating the efficacy of HBV vaccine.…”
Section: Introductionmentioning
confidence: 99%
“…6,8 However several surveys of voluntary blood donors in the Kingdom of Saudi Arabia have shown marked regional variations in the prevalence of HBV. [9][10][11][12] In the region of Tabuk, which occupies the northwestern part of Saudi Arabia, information on the epidemiology and prevalence of HBV infection among the different population groups is inadequate. Most of the previous studies in the region have been limited to children less than 12 years of age as part of national studies aiming at evaluating the efficacy of HBV vaccine.…”
Section: Introductionmentioning
confidence: 99%